Materias dentro de su búsqueda.
Mostrando 381 - 400 Resultados de 23,153 Para Buscar '"Epping"', tiempo de consulta: 0.63s Limitar resultados
  1. 381
    “…Using the Cell-Based Immunization and Screening (CBIS) method, we previously established an anti-EpCAM monoclonal antibody (EpMab-37; mouse IgG(1), kappa). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG(2a)-f) Exerts Antitumor Activity in Xenograft Model
  2. 382
    “…METHODS: We conducted semi-structured interviews and focus groups (09/2018-07/2019) with patients who identified as gay or bisexual men and were either using PrEP, had declined the offer of PrEP, had stopped PrEP, or had been assessed as ineligible for PrEP (n = 39 of whom n = 5 (13%) identified as trans, median age 31 years and interquartile range 14 years), healthcare professionals involved in PrEP provision (n = 54 including specialist sexual health doctors and nurses of various grades, PrEP prescribing general practitioners, health promotion officers, midwifes, and a PrEP clinical secretary), and clients (n = 9) and staff (n = 15) of non-governmental organisations with an HIV prevention remit across Scotland. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Improving HIV pre-exposure prophylaxis (PrEP) adherence and retention in care: Process evaluation and recommendation development from a nationally implemented PrEP programme
  3. 383
    “…Selective stimulation of EP(2) or EP(4) receptors attenuates histamine-evoked Ca(2+) signals, but the effects of PGE(2) on both Ca(2+) signals and AC activity are largely mediated by EP(2) receptors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ca(2+) signals evoked by histamine H(1) receptors are attenuated by activation of prostaglandin EP(2) and EP(4) receptors in human aortic smooth muscle cells
  4. 384
    “…Epithelial cell adhesion molecule (EpCAM) was reported to be cleaved into extracellular domain of EpCAM (EpEX) and intracellular domain of EpCAM (EpICD). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α
  5. 385
    “…BACKGROUND: Pre-exposure prophylaxis (PrEP) is a promising and effective tool to prevent HIV. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol
  6. 386
    “…INTRODUCTION: The World Health Organization, while recommending pre‐exposure prophylaxis (PrEP) for HIV‐negative pregnant and postpartum women in HIV high‐burden settings, advocates for continued safety evaluation of PrEP in this population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Perinatal outcomes following maternal pre‐exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya
  7. 387
    “…Upon internalization, receptors are trafficked to sorting endosomes (SE) where they undergo sorting and are then packaged into budding vesicles that undergo fission and transport within the cell. Eps15 Homology Domain Protein 1 (EHD1), the best-characterized member of the Eps15 Homology Domain Protein (EHD) family, has been implicated in catalyzing the fission process that releases endosome-derived vesicles for recycling to the plasma membrane. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Eps15 Homology Domain Protein 4 (EHD4) is required for Eps15 Homology Domain Protein 1 (EHD1)-mediated endosomal recruitment and fission
  8. 388
    “…BACKGROUND: Optimising HIV pre-exposure prophylaxis (PrEP) provision requires insight into preferences of PrEP regimens and PrEP discontinuation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men
  9. 389
    “…Methods: Using data from PrEP Chicago, an RCT PrEP for prevention intervention for young Black MSM (YBMSM), we apply stochastic actor-based models to longitudinally model the impact of study participation on the online friendship and PrEP adoption dynamics among a network of peer leaders (n = 174) and a network of control group counterparts (n = 166). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Co-Evolution of Network Structure and PrEP Adoption among a Large Cohort of PrEP Peer Leaders: Implications for Intervention Evaluation and Community Capacity-Building
  10. 390
    “…PrEP uptake was defined as dispensation of PrEP, PrEP retention was defined as proportion of expected visits completed among those who initiated PrEP, and PrEP adherence was assessed by measuring tenofovir diphosphate concentrations in dried blood spots. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California
  11. 391
    “…Although a commercially available antibody indicated loss of cell-surface expression, the EpCAM targeting bispecific COBRA was still able to lyse these cells in a T cell dependent cellular cytotoxicity assay. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager
  12. 392
    “…We examined PrEP use, condomless anal sex (CAS), and PrEP adherence among men who have sex with men (MSM) attending sexual health clinics in Wales, UK. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PrEP Use, Sexual Behaviour, and PrEP Adherence Among Men who have Sex with Men Living in Wales Prior to and During the COVID-19 Pandemic
  13. 393
    “…On-demand PrEP may meet the needs of MSM who infrequently use condoms and other prevention methods.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PrEP in the Context of Other HIV Risk Reduction Strategies Among Men Who Have Sex with Men: Results from the Flash! PrEP in Europe Survey
  14. 394
    “…Scare evidence is available to assess the quality of patient-provider communication via the platform of telemedicine, especially for PrEP care within primary care settings. (2) Methods: Participants included 18 primary care providers and 29 PrEP-eligible women. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Telemedicine Experience for PrEP Care among PrEP-Eligible Women and Their Primary Care Providers during the First Year of the COVID-19 Pandemic in the United States
  15. 395
    “…BACKGROUND: Pre-exposure prophylaxis (PrEP) has demonstrated effectiveness in high-risk populations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PrEP stigma among current and non-current PrEP users in Thailand: A comparison between hospital and key population-led health service settings
  16. 396
    por Sauli, Fabio
    Publicado 1982
    Enlace del recurso
    New developments in gaseous detectors (CERN-EP-INT-82-03)
  17. 397
    Enlace del recurso
    Liste des rapports - Division EP/EF (janvier - juin 1976)
  18. 398
    por Alexa, C., Andreev, V., Baghdasaryan, A., Baghdasaryan, S., Bartel, W., Begzsuren, K., Belousov, A., Belov, P., Boudry, V., Bozovic-Jelisavcic, I., Brandt, G., Brinkmann, M., Brisson, V., Britzger, D., Buniatyan, A., Bylinkin, A., Bystritskaya, L., Campbell, A.J., Cantun Avila, K.B., Ceccopieri, F., Cerny, K., Chekelian, V., Contreras, J.G., Cvach, J., Dainton, J.B., Daum, K., De Wolf, E.A., Diaconu, C., Dobre, M., Dodonov, V., Dossanov, A., Eckerlin, G., Egli, S., Elsen, E., Favart, L., Fedotov, A., Felst, R., Feltesse, J., Ferencei, J., Fischer, D.J., Fleischer, M., Fomenko, A., Gabathuler, E., Gayler, J., Ghazaryan, S., Glazov, A., Goerlich, L., Gogitidze, N., Gouzevitch, M., Grab, C., Grebenyuk, A., Greenshaw, T., Grindhammer, G., Habib, S., Haidt, D., Henderson, R.C.W., Hennekemper, E., Herbst, M., Herrera, G., Hildebrandt, M., Hiller, K.H., Hladky, J., Hoffmann, D., Horisberger, R., Hreus, T., Huber, F., Jacquet, M., Janssen, X., Jonsson, L., Jung, H., Kapichine, M., Kiesling, C., Klein, M., Kleinwort, C., Kogler, R., Kostka, P., Kramer, M., Kretzschmar, J., Kruger, K., Landon, M.P.J., Lange, W., Laycock, P., Lebedev, A., Levonian, S., Lipka, K., List, B., List, J., Lobodzinski, B., Lopez-Fernandez, R., Lubimov, V., Malinovski, E., Martyn, H.U., Maxfield, S.J., Mehta, A., Meyer, A.B., Meyer, H., Meyer, J., Mikocki, S., Milcewicz-Mika, I., Morozov, A., Morris, J.V., Muller, K., Naumann, Th., Newman, P.R., Niebuhr, C., Nikitin, D., Nowak, G., Nowak, K., Olsson, J.E., Ozerov, D., Pahl, P., Palichik, V., Pandurovic, M., Pascaud, C., Patel, G.D., Perez, E., Petrukhin, A., Picuric, I., Pirumov, H., Pitzl, D., Placakyte, R., Pokorny, B., Polifka, R., Radescu, V., Raicevic, N., Ravdandorj, T., Reimer, P., Rizvi, E., Robmann, P., Roosen, R., Rostovtsev, A., Rotaru, M., Ruiz Tabasco, J.E., Rusakov, S., Salek, D., Sankey, D.P.C., Sauter, M., Sauvan, E., Schmitt, S., Schoeffel, L., Schoning, A., Schultz-Coulon, H.C., Sefkow, F., Shushkevich, S., Soloviev, Y., Sopicki, P., South, D., Spaskov, V., Specka, A., Staykova, Z., Steder, M., Stella, B., Stoicea, G., Straumann, U., Sykora, T., Thompson, P.D., Traynor, D., Truol, P., Tsakov, I., Tseepeldorj, B., Turnau, J., Valkarova, A., Vallee, C., Van Mechelen, P., Vazdik, Y., Wegener, D., Wunsch, E., Zacek, J., Zalesak, J., Zhang, Z., Zlebcik, R., Zohrabyan, H., Zomer, F.
    Publicado 2013
    “…Charged particle production in deep-inelastic ep scattering is measured with the H1 detector at HERA. …”
    Enlace del recurso
    Enlace del recurso
    Measurement of Charged Particle Spectra in Deep-Inelastic ep Scattering at HERA
  19. 399
    Enlace del recurso
    Enlace del recurso
    Chapter XIV: Physics of ep collisions in the TeV energy range
  20. 400
    por Cornet, F, Rückl, R
    Publicado 1987
    Enlace del recurso
    Enlace del recurso
    Searches for a new Z' boson in ep collisions at LEP-LHC
Herramientas de búsqueda: RSS